Article Versions Notes

Partridge SC, Steingrimsson J, Newitt DC, Gibbs JE, Marques HS, Bolan PJ, Boss MA, Chenevert TL, Rosen MA, Hylton NM. Impact of Alternate b-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 Trial. Tomography. 2022; 8(2):701-717. https://doi.org/10.3390/tomography8020058

Partridge, Savannah C., Jon Steingrimsson, David C. Newitt, Jessica E. Gibbs, Helga S. Marques, Patrick J. Bolan, Michael A. Boss, Thomas L. Chenevert, Mark A. Rosen, and Nola M. Hylton. 2022. "Impact of Alternate b-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 Trial" Tomography 8, no. 2: 701-717. https://doi.org/10.3390/tomography8020058

Partridge, S. C., Steingrimsson, J., Newitt, D. C., Gibbs, J. E., Marques, H. S., Bolan, P. J., Boss, M. A., Chenevert, T. L., Rosen, M. A., & Hylton, N. M. (2022). Impact of Alternate b-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 Trial. Tomography, 8(2), 701-717. https://doi.org/10.3390/tomography8020058